Telomerase activity in human hematopoietic progenitor cells

Haematologica

Volumn 82, Issue 3, 1997, Pages 262-268

  Hohaus, Stefan ^a,b   Voso, Maria Teresa ^a   Ortu La Barbera, Elettra ^a   Cavallo, Salvatore ^a   Bellacosa, Alfonso ^a   Rutella, Sergio ^a   Rumi, Carlo ^a   Genuardi, Maurizio ^a   Neri, Giovanni ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CD34+ cells; PBSCT; Telomerase

Indexed keywords

TELOMERASE;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CLONOGENIC ASSAY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PROTEIN EXPRESSION;

ANTIGENS, CD34; BLOOD CELLS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; ENZYME INDUCTION; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOMA; LYMPHOMA, LARGE-CELL, DIFFUSE; POLYMERASE CHAIN REACTION; TELOMERASE; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0031438956     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Blackburn EH. Structure and function of telomeres. Nature 1991; 350:569-73.
2. De Lange T, Shiue L, Myers RM, et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990; 10:518-27.
3. Greider CW. Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr Opin Gen Dev 1994; 4:203-11.
4. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11:1921-9.
5. Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Gen Dev 1995; 5:249-55.
6. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990; 346:866-8.
7. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with aging. Nature 1990; 346:866-8.
8. Allsopp RC, Vaziri H, Patterson F, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89:10114-8.
9. Vaziri H, Schachter F, Uchida I, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993; 52:661-7.
10. Slagboom PE, Droog S, Boomsma DI. Genetic detemination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994; 55:876-82.
11. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521-9.
12. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5.
13. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995; 1:249-55.
14. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995, 55:3258-62.
15. Chadeneau C, Hay K, Hirte H, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55:2533-6.
16. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55:2734-6.
17. Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995; 87: 895-902.
18. Langford LA, Piatyszek MA, Xu R, Schold SC, Shay JW. Telomerase activity in human brain tumors. Lancet 1995; 346:1267-8.
19. Hohaus S, Cavallo S, Bellacosa A, et al. Telomerase activity in human laryngeal squamous cell carciomas. Clin Cancer Res 1996; 2: 1895-900.
20. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996; 56:218-22.
21. Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996; 88:116-22.
22. Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G. Telomerase activity in human renal cell carcinoma. Oncogene 1996; 13:161-6
23. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad USA 1994; 91:9857-60.
24. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85:2315-20.
25. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155:3711-5.
26. Wan JH, Trainor KJ, Brisco MJ, Morley AA. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 1990; 43:888-90.
27. Voso MT, Burn TC, Wulf G, Lim B, Leone G, Tenen DG. Inhibition of hematopoiesis by competitive binding of the transcription factor PU.1. Proc Natl Acad Sci USA 1994; 91:7932-6.
28. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thyocyanate-phenol-chloroform extraction. Ann Biochem 1987; 162:156-9.
29. Fleming JC, Pahl HL, Gonzalez DA, Smith TF, Tenen DG. Structural analysis of the CD11b gene and phylogenetic analysis of the a-integrin gene family demonstrates remarkable conservation of genomic organization and suggest early diversification during evolution. J Immunol 1993; 2:480-90.
30. Arcari P, Martinelli R, Salvatore F. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res 1994; 12:9179-83.
31. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1990; 132:6-8.
32. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993; 21:508-14.
33. Morrison SJ, Prowse KR, Ho P, Weissman IL. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 1996; 5:207-8.
34. Sharma HW, Sokoloski JA, Perez JR, et al. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad USA 1995; 92: 12343-6.
35. Albanell J, Han W, Mellado B, et al. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res 1996; 56:1503-8.
36. Savoysky E, Yoshida K, Ohtomo T, et al. Down-regulation of telomerase activity is an early event in the differentiation of HL60 cells. Biochem Biophys Res Comm 1996; 226:329-34.
37. Xu D, Gruber A, Peterson C, Pisa P. Suppression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia 1996; 10:1354-7.
38. Bestilny LJ, Brown CB, Miura Y, Robertson LD, Riabowol KT. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res 1996; 56:3796-802.
39. Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 1996; 16:2932-9.
40. Zhu X, Kumar R, Mandal M, et al. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA 1996; 93:6091-5.
41. Roberts AW, Metcalf D. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood 1995; 86:600-5.
42. Rutella S, Rumi C, Teofili L, Etuk B, Ortu-La Barbera E, Leone G. RhG-CSF mobilized peripheral blood haematopoietic progenitors reside in G0/G1 phase of cell cycle independently of the expression of myeloid antigens. Br J Haematol 1996; 93:737-8.
43. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinima-derived skin keratinocytes. Proc Natl Acad Sci USA 1996; 93:6476-81.
44. Norrback KF, Dahlenborg K, Carlsson, Roos G. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 1996; 88:222-9.
45. Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996; 183:2471-9.
46. Almici C, Carlo Stella C, Wagner JE, Rizzoli V. Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical application. Haematologica 1995; 80:473-9.
47. Carlo Stella C, Tabilio A. Stem cells and stem cell transplantation. Haematologica 1996; 81:573-87.
48. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995; 269:1236-41.